Back to mobile site

Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $21 at Mizuho, 'a current top pick'

April 28, 2026 6:35 AM EDT Send to a Friend
Mizuho analyst Graig Suvannavejh raised the price target on Amylyx Pharmaceuticals inc. (NASDAQ: AMLX) to $21.00 (from $19.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login